Literature DB >> 3974684

Tubal infertility and the intrauterine device.

D W Cramer, I Schiff, S C Schoenbaum, M Gibson, S Belisle, B Albrecht, R J Stillman, M J Berger, E Wilson, B V Stadel.   

Abstract

To study the association between intrauterine devices (IUDs) and pelvic inflammatory disease, we compared contraceptive histories in 4185 while women--283 nulliparous women with primary tubal infertility, 69 women with secondary tubal infertility, and 3833 women admitted for delivery at seven collaborating hospitals from 1981 to 1983. The relative risk of tubal infertility associated with IUD use was calculated by means of multivariate logistic regression to control for confounding factors, including region, year of menarche, religion, education, smoking, and reported number of sexual partners. The adjusted risk of primary tubal infertility associated with any IUD use before a first live birth was 2.0 (95 per cent confidence limits, 1.5 to 2.6) relative to nonuse. Users of the Dalkon Shield had an adjusted risk of 3.3 (1.7 to 6.1), users of the Lippes Loop or Saf-T-Coil had a risk of 2.9 (1.7 to 5.2), and users of copper IUDs had a risk of 1.6 (1.1 to 2.4). Women who reported having only one sexual partner had no increased risk of primary tubal infertility associated with IUD use. The adjusted risk of secondary tubal infertility associated with use of a copper IUD after a first live birth was not statistically significant (1.5; 95 per cent confidence limits, 0.8 to 3.0), whereas the risk from similar use of noncopper devices was significant (2.8; 1.3 to 5.9). We conclude that tubal infertility is associated with IUD use, but less so with copper IUDs.

Entities:  

Keywords:  Adnexal Effects; Biology; Clinical Research; Contraception; Contraceptive Methods--complications; Diseases; Fallopian Tubes; Family Planning; Genital Effects, Female; Genitalia; Genitalia, Female; Infections; Infertility--etiology; Iud, Copper Releasing--complications; Iud, Unmedicated--complications; Iud--complications; Physiology; Population At Risk; Reproduction; Research Methodology; Tubal Effects--etiology; Urogenital Effects; Urogenital System

Mesh:

Year:  1985        PMID: 3974684     DOI: 10.1056/NEJM198504113121502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

1.  Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability.

Authors:  Donna D Baird; Anne Z Steiner
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

2.  Barriers to prescribing the Copper T 380A intrauterine device by physicians.

Authors:  C H Kooiker; F D Scutchfield
Journal:  West J Med       Date:  1990-09

Review 3.  Contraception.

Authors:  A Szarewski; J Guillebaud
Journal:  BMJ       Date:  1991-05-25

4.  Public knowledge of AIDS and the DHSS advertisement campaign.

Authors:  S Mills; M J Campbell; W E Waters
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

5.  Fertility after intrauterine device removal: a pilot study.

Authors:  Amy M Stoddard; Hanna Xu; Tessa Madden; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Eur J Contracept Reprod Health Care       Date:  2015-03-09       Impact factor: 1.848

Review 6.  Pelvic inflammatory disease: current concepts and treatment guidelines.

Authors:  P A Dale; P A Rice; K C Edelin
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

7.  Infertility in women and moderate alcohol use.

Authors:  F Grodstein; M B Goldman; D W Cramer
Journal:  Am J Public Health       Date:  1994-09       Impact factor: 9.308

8.  The public and the pill: is the pill making a comeback?

Authors:  J D Forrest
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

9.  Age and fertility: how late can you wait?

Authors:  J Menken
Journal:  Demography       Date:  1985-11

Review 10.  Tubo-ovarian abscess: pathogenesis and management.

Authors:  N G Osborne
Journal:  J Natl Med Assoc       Date:  1986-10       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.